ABC008

( DrugBank: - / KEGG DRUG: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
15	Inclusion body myositis	2

15. Inclusion body myositis

Clinical trials : 42 / Drugs : 33 - (DrugBank : 11) / Drug target genes : 12 - Drug target pathways : 123

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05721573 (ClinicalTrials.gov)	February 28, 2023	1/2/2023	A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis	A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Effic ...	Inclusion Body Myositis	Drug: ABC008	Abcuro, Inc.	Syneos Health	Recruiting	40 Years	N/A	All	231	Phase 2/Phase 3	United States
2	NCT04659031 (ClinicalTrials.gov)	May 25, 2021	25/11/2020	A Phase 1 Study of ABC008in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patie ...	A Phase 1, Open-Label, Ascending Dose Study of ABC008in Adult Patients With Inclusion Body Myositis ...	Inclusion Body Myositis	Drug: ABC008	Abcuro, Inc.	NULL	Recruiting	40 Years	N/A	All	30	Phase 1	Australia

First Previous1Next Last